Tap Consulting, LLC Axsome Therapeutics, Inc. Transaction History

Tap Consulting, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 26, 2022	SELL	$21.74 - $46.75 $835,446 - $1.8 Million	-38,429 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$23.7 - $41.39 $910,767 - $1.59 Million	38,429 New	38,429 $1.59 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.06B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

Stay updated on Tap Consulting, LLC with notifications on news.